SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-24-000021
Filing Date
2024-11-07
Accepted
2024-11-07 16:14:34
Documents
15
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20241107x8k.htm   iXBRL 8-K 44897
2 EX-99.1 tmb-20241107xex99d1.htm EX-99.1 171224
  Complete submission text file 0001070081-24-000021.txt   356021

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20241107.xsd EX-101.SCH 3934
4 EX-101.DEF tmb-20241107_def.xml EX-101.DEF 2806
5 EX-101.LAB tmb-20241107_lab.xml EX-101.LAB 16547
6 EX-101.PRE tmb-20241107_pre.xml EX-101.PRE 9655
17 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241107x8k_htm.xml XML 4679
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 241435907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)